Product Description
Mechanisms of Action: No Mechanism
Novel Mechanism: No
Modality: Large Molecule
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Biostime
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
|---|---|---|---|---|---|
| NCT05300152 | N/A |
Completed |
Tooth, Nonvital|Root Resorption|Tooth Resorption |
2024-07-12 |
|
| ChiCTR2000029120 | N/A |
Not yet recruiting |
Unknown |
2021-02-01 |
|
| ChiCTR2000029139 | N/A |
Not yet recruiting |
Unknown |
2021-02-01 |
|
| MVasCDN | N/A |
Unknown status |
Kidney Diseases|Vascular Calcification|Diabetic Nephropathy|Calcinosis |
2020-07-01 |